Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.200
+0.006 (2.88%)
At close: Nov 4, 2024, 4:00 PM
0.196
-0.005 (-2.25%)
After-hours: Nov 4, 2024, 4:56 PM EST
Viracta Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 8 | 22 | 56 | 136 | - | - | |
| Market Cap Growth | -60.57% | -60.52% | -59.05% | - | - | - | |
| Enterprise Value | 2 | -10 | -11 | 36 | - | - | |
| Last Close Price | 0.20 | 0.57 | 1.46 | 3.65 | - | - | |
| PE Ratio | - | -0.43 | -1.12 | -1.01 | - | - | |
| PB Ratio | 7.99 | 1.20 | 0.91 | 1.44 | - | - | |
| P/FCF Ratio | -0.56 | -0.55 | -1.57 | -7.13 | - | - | |
| P/OCF Ratio | -0.56 | -0.55 | -1.57 | -7.22 | - | - | |
| EV/EBITDA Ratio | -0.12 | 0.20 | 0.21 | -0.93 | - | - | |
| EV/EBIT Ratio | -0.12 | 0.20 | 0.21 | -0.93 | - | - | |
| EV/FCF Ratio | -0.16 | 0.25 | 0.30 | -1.91 | - | - | |
| Debt / Equity Ratio | 7.05 | 1.40 | 0.41 | 0.06 | 0.17 | 0.01 | |
| Debt / FCF Ratio | -0.49 | -0.64 | -0.71 | -0.29 | -0.38 | -0.01 | |
| Quick Ratio | 1.05 | 1.41 | 9.23 | 11.40 | 7.49 | 7.61 | |
| Current Ratio | 1.08 | 1.43 | 9.36 | 11.59 | 7.51 | 7.64 | |
| Return on Equity (ROE) | -208.67% | -128.57% | -63.29% | -174.44% | -71.42% | -186.10% | |
| Return on Assets (ROA) | -57.20% | -41.50% | -30.92% | -31.32% | -35.23% | -63.93% | |
| Return on Capital (ROIC) | -70.45% | -48.69% | -33.98% | -34.30% | -39.49% | -77.20% | |
| Earnings Yield | -575.08% | -231.91% | -88.22% | -84.27% | - | - | |
| FCF Yield | -484.40% | -181.82% | -63.66% | -14.03% | - | - | |
| Buyback Yield / Dilution | -2.06% | -2.21% | -18.58% | -9714.39% | 86.22% | -145.73% | |
| Total Shareholder Return | -2.06% | -2.21% | -18.58% | -9714.39% | 86.22% | -145.73% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.